These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4273519)

  • 21. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding.
    Jiao J; Yu M; Ru B
    Biochim Biophys Acta; 2001 Apr; 1546(2):399-405. PubMed ID: 11295444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of bile salts on the esterase activities of plasmin and some other enzymes.
    Exner T; Koppel JL
    Biochim Biophys Acta; 1973 Sep; 321(1):303-18. PubMed ID: 4270801
    [No Abstract]   [Full Text] [Related]  

  • 23. The activation of type 1 and type 2 plasminogen by type I and type II tissue plasminogen activator.
    Mori K; Dwek RA; Downing AK; Opdenakker G; Rudd PM
    J Biol Chem; 1995 Feb; 270(7):3261-7. PubMed ID: 7852411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of chemical anti-inhibitors on fibrinolytic enzymes and inhibitors.
    Sidelmann J; Jespersen J; Kluft C; Gram J
    Clin Chim Acta; 1997 May; 261(1):43-56. PubMed ID: 9187504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the primary structure of human plasminogen and plasmin. Purification and characterization of cyanogen-bromide fragments.
    Wiman B; Wallén P
    Eur J Biochem; 1975 Sep; 57(2):387-94. PubMed ID: 126158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation pathway of glu-plasminogen to Lys-plasmin by urokinase.
    Takada A; Takada Y
    Thromb Res; 1982 Sep; 27(6):671-7. PubMed ID: 6129717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interaction of streptokinase with human, cat, dog, and rabbit plasminogens. The fragmentation of streptokinase in the equimolar plasminogen-streptokinase complexes.
    Summaria L; Arzadon L; Bernabe P; Robbins KC
    J Biol Chem; 1974 Aug; 249(15):4760-9. PubMed ID: 4846746
    [No Abstract]   [Full Text] [Related]  

  • 28. The subunit structure of yeast pyruvate kinase.
    Bornmann L; Hess B
    Eur J Biochem; 1974 Aug; 47(1):1-4. PubMed ID: 4434983
    [No Abstract]   [Full Text] [Related]  

  • 29. Activation of human plasminogen by recombinant staphylokinase.
    Trieu T; Behnke D; Gerlach D; Tang J
    Methods Enzymol; 1993; 223():156-67. PubMed ID: 8271950
    [No Abstract]   [Full Text] [Related]  

  • 30. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).
    Petersen LC
    Eur J Biochem; 1997 Apr; 245(2):316-23. PubMed ID: 9151959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary structure of peptides released during activation of human plasminogen by urokinase.
    Wiman B
    Eur J Biochem; 1973 Nov; 39(1):1-9. PubMed ID: 4770790
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
    Müllertz S; Thorsen S; Sottrup-Jensen L
    Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The conversion of prothrombin to thrombin. II. Differentiation between thrombin- and factor Xa-catalyzed proteolyses.
    Esmon CT; Owen WG; Jackson CM
    J Biol Chem; 1974 Jan; 249(2):606-11. PubMed ID: 4809531
    [No Abstract]   [Full Text] [Related]  

  • 34. Isolation and characterization of urokinase from human plasma.
    Wun TC; Schleuning WD; Reich E
    J Biol Chem; 1982 Mar; 257(6):3276-83. PubMed ID: 7037781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and chemical characterization of a mitogenic lectin from Pisum sativum.
    Trowbridge IS
    J Biol Chem; 1974 Sep; 249(18):6004-12. PubMed ID: 4414003
    [No Abstract]   [Full Text] [Related]  

  • 36. Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor, a plasminogen activator.
    Unkeless J; Dano K; Kellerman GM; Reich E
    J Biol Chem; 1974 Jul; 249(13):4295-305. PubMed ID: 4368727
    [No Abstract]   [Full Text] [Related]  

  • 37. Activation of human neo-plasminogen-Val442 by urokinase and streptokinase and a kinetic characterization of neoplasmin-Val442.
    Powell JR; Castellino FJ
    J Biol Chem; 1980 Jun; 255(11):5329-35. PubMed ID: 6445361
    [No Abstract]   [Full Text] [Related]  

  • 38. The relationship of fibrinogen structure to plasminogen activation and plasmin activity during fibrinolysis.
    Lucas MA; Fretto LJ; McKee PA
    Ann N Y Acad Sci; 1983 Jun; 408():71-91. PubMed ID: 6223562
    [No Abstract]   [Full Text] [Related]  

  • 39. On the mechanism of the reaction between human alpha 2-antiplasmin and plasmin.
    Wiman B; Collen D
    J Biol Chem; 1979 Sep; 254(18):9291-7. PubMed ID: 158022
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular mechanisms of thrombolytic therapy.
    Lijnen HR; Collen D
    Haemostasis; 1986; 16 Suppl 3():3-15. PubMed ID: 2945766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.